TOCA News and Press, Tocagen

SAN DIEGO , May 28, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, announced today that, due to public health and safety concerns related to the COVID-19 global pandemic, recommendations and orders from federal, stat...

Broadwind Energy (NASDAQ: BWEN ) +60% . on $19M order . More news on: Broadwind Energy, Inc., TrovaGene, Inc., SmileDirectClub, Inc., Stocks on the move, , Read more ...

Tocagen (NASDAQ: TOCA ): Q1 GAAP EPS of -$0.43 beats by $0.01 . More news on: Tocagen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN DIEGO , April 23, 2020 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), historically a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended March 31, 2020 . On February 19, 2020 , Tocagen announced it ha...

Tocagen Continues Merger-Fueled Upswing Tocagen ( TOCA ) stock shot up as the company follows through its previous announcement about a merger with Forte Biosciences, an obscure pharmaceuticals firm with FB-401 as its lead candidate. FB-401 is a topical drug designed to treat inflammatory ...

Nano cap Tocagen ( TOCA +27.2% ) jumps on 49% higher volume, adding to its announced merger -stoked rally that began on February 19. Shares are up  187%  since then. More news on: Tocagen Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read...

Gainers: Digirad DRAD  +122% . More news on: Tocagen Inc., Menlo Therapeutics Inc., ObsEva SA, Stocks on the move, , Read more ...

Speculation & News Are Driving Momentum For These Penny Stocks If there’s one thing we’ve learned from penny stocks it’s that speculation can make for exciting times. While these cheap stocks are already volatile and high risk, events like the novel coronavirus or COVI...

Tocagen (NASDAQ: TOCA ): Q4 GAAP EPS of -$0.44 beats by $0.13 . More news on: Tocagen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

SAN DIEGO , Feb. 27, 2020 /PRNewswire/ --  Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2019 . "Following our extensive...